501 related articles for article (PubMed ID: 34367154)
1. Gene Expression Meta-Analysis Reveals Interferon-Induced Genes Associated With SARS Infection in Lungs.
Park A; Harris LK
Front Immunol; 2021; 12():694355. PubMed ID: 34367154
[TBL] [Abstract][Full Text] [Related]
2. Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us.
Kumar V
Int Rev Immunol; 2021; 40(1-2):5-53. PubMed ID: 32744465
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
Front Immunol; 2021; 12():629193. PubMed ID: 33732251
[TBL] [Abstract][Full Text] [Related]
4. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Immune Response between SARS, MERS, and COVID-19 Infection, Perspective on Vaccine Design and Development.
Ansariniya H; Seifati SM; Zaker E; Zare F
Biomed Res Int; 2021; 2021():8870425. PubMed ID: 33564683
[TBL] [Abstract][Full Text] [Related]
6. Immunological map in COVID-19.
Li CH; Chiou HC; Lin MH; Kuo CH; Lin YC; Lin YC; Hung CH; Kuo CH
J Microbiol Immunol Infect; 2021 Aug; 54(4):547-556. PubMed ID: 34023234
[TBL] [Abstract][Full Text] [Related]
7. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D.
Zheng J; Meyerholz D; Wong LR; Gelb M; Murakami M; Perlman S
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060490
[TBL] [Abstract][Full Text] [Related]
9. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.
Atzrodt CL; Maknojia I; McCarthy RDP; Oldfield TM; Po J; Ta KTL; Stepp HE; Clements TP
FEBS J; 2020 Sep; 287(17):3633-3650. PubMed ID: 32446285
[TBL] [Abstract][Full Text] [Related]
10. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
Liu WJ; Zhao M; Liu K; Xu K; Wong G; Tan W; Gao GF
Antiviral Res; 2017 Jan; 137():82-92. PubMed ID: 27840203
[TBL] [Abstract][Full Text] [Related]
11. A double edged-sword - The Complement System during SARS-CoV-2 infection.
Santiesteban-Lores LE; Amamura TA; da Silva TF; Midon LM; Carneiro MC; Isaac L; Bavia L
Life Sci; 2021 May; 272():119245. PubMed ID: 33609539
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting.
Abdirizak F; Lewis R; Chowell G
Theor Biol Med Model; 2019 Oct; 16(1):16. PubMed ID: 31587665
[TBL] [Abstract][Full Text] [Related]
13. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
14. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2.
İnandıklıoğlu N; Akkoc T
Adv Exp Med Biol; 2020; 1288():5-12. PubMed ID: 32514817
[TBL] [Abstract][Full Text] [Related]
15. Surviving the Rookie Virus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): The Immunopathology of a SARS-CoV2 Infection.
Tsai SF; Lu KY; Chuang HM; Liu CA
Cell Transplant; 2021; 30():963689721993769. PubMed ID: 33840257
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus vaccine development: from SARS and MERS to COVID-19.
Li YD; Chi WY; Su JH; Ferrall L; Hung CF; Wu TC
J Biomed Sci; 2020 Dec; 27(1):104. PubMed ID: 33341119
[TBL] [Abstract][Full Text] [Related]
17. MERS-CoV and SARS-CoV infections in animals: a systematic review and meta-analysis of prevalence studies.
Bonilla-Aldana DK; Cardona-Trujillo MC; García-Barco A; Holguin-Rivera Y; Cortes-Bonilla I; Bedoya-Arias HA; Patiño-Cadavid LJ; Tamayo-Orozco JD; Paniz-Mondolfi A; Zambrano LI; Dhama K; Sah R; Rabaan AA; Balbin-Ramon GJ; Rodriguez-Morales AJ
Infez Med; 2020 Jun; 28(suppl 1):71-83. PubMed ID: 32532942
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Comparison of RNA-Seq Data of SARS-CoV-2, SARS-CoV and MERS-CoV Infections: Alternative Entry Routes and Innate Immune Responses.
Cao Y; Xu X; Kitanovski S; Song L; Wang J; Hao P; Hoffmann D
Front Immunol; 2021; 12():656433. PubMed ID: 34122413
[TBL] [Abstract][Full Text] [Related]
19. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
[TBL] [Abstract][Full Text] [Related]
20. Impact of COVID-19 on Pregnancy.
Wang CL; Liu YY; Wu CH; Wang CY; Wang CH; Long CY
Int J Med Sci; 2021; 18(3):763-767. PubMed ID: 33437211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
